Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The relationship between diffuse axonal damage and fatigue in multiple sclerosis.

Maria Carmela Tartaglia1, Sridar Narayanan, Simon J Francis

  • 1Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, Montreal, Quebec, Canada.

Archives of Neurology
|February 18, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Indirect structural disconnection-symptom mapping of haptic graviceptic neglect after stroke.

Annals of physical and rehabilitation medicine·2026
Same author

Quantitative Choroid Plexus Gadolinium Enhancement Is Related to Diffuse Brain Tissue Injury in Multiple Sclerosis.

Journal of neuroimaging : official journal of the American Society of Neuroimaging·2026
Same author

Efficacy of Ublituximab in People with Highly Active Relapsing Multiple Sclerosis.

Neurology and therapy·2026
Same author

Subcortical microglial inflammation is uniquely linked to subpial cortical demyelination in multiple sclerosis.

NeuroImage. Clinical·2026
Same author

Brain atrophy rates vary with age in relapsing-remitting multiple sclerosis.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

Reduced fibre-fermenting capacity of gut microbes in multiple sclerosis may result in prebiotic dietary fibre β-fructan promoting inflammation and CNS damage.

eGastroenterology·2026

Multiple sclerosis (MS) fatigue is linked to brain axonal damage. Proton magnetic resonance spectroscopy revealed lower N-acetylaspartate levels in MS patients with severe fatigue, indicating a central nervous system cause.

Area of Science:

  • Neuroscience
  • Neurology
  • Biomedical Imaging

Background:

  • Fatigue is a prevalent and debilitating symptom in multiple sclerosis (MS).
  • Evidence suggests a central nervous system origin for MS-related fatigue.
  • This study investigated the association between diffuse cerebral axonal damage and fatigue in MS patients.

Purpose of the Study:

  • To evaluate the correlation between central brain N-acetylaspartate (NAA) levels and fatigue severity in MS.
  • To determine if axonal damage, measured by NAA, is a significant factor in MS fatigue.

Main Methods:

  • Proton magnetic resonance spectroscopy (MRS) was employed to noninvasively assess axonal damage in the brains of MS patients.
  • Data from 73 MS patients, including MRS imaging and Fatigue Severity Scale (FSS) scores, were analyzed.

Related Experiment Videos

  • N-acetylaspartate-creatine ratio (NAA/Cr) was calculated as a marker of neuronal integrity.
  • Main Results:

    • The N-acetylaspartate-creatine ratio (NAA/Cr) was significantly lower in MS patients reporting high fatigue levels compared to those with low fatigue (P =.003).
    • This reduction in NAA/Cr was independent of disease severity (Kurtzke Expanded Disability Status Scale), lesion load, age, and disease duration.
    • A significant negative linear correlation was observed between FSS scores and NAA/Cr (Spearman rho = -0.361, P =.02), indicating more fatigue with lower NAA/Cr.

    Conclusions:

    • Widespread axonal dysfunction in the brain is associated with fatigue in multiple sclerosis.
    • Altered brain function and increased neural pathway recruitment may contribute to the perception of increased effort in MS patients.
    • Proton MRS offers a noninvasive method to explore the neurobiological underpinnings of MS fatigue.